First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
more
- Language:
- Media:
- Period:
- Period:Total
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreLTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
more
1